FDA’s Quality Management Maturity Program:
Why should CDMOs adhere to the new CDER’s Rating System?

Bispecific antibodies unleashed

CMC Best Practices: Expediting Orphan Drug Development to Combat Rare Disease

Comprehensive mRNA Solutions

The M.O. Behind Choosing a CDMO: Three Considerations for New Drug Developers

Rapid Drug Manufacturing Scale-Up: Best Practices

Casual Nexus – Episode Two: T3P – A Versatile Peptide Coupling and Water Removal Reagent

From Niche to Transformational: Using Biology for Chemistry in Pharmaceutical Development

Chemistry Through Biology: Translating Molecular Biology Technologies into Practical Processes for API Production

Key Considerations for End-to-End Primary Packaging Solutions for Pharmaceuticals & Devices

Solid Form Selection in Drug Development

Creating Compound Screening Libraries that Address the Challenges of Drug Discovery